Japan· JP-2234400A1054
ブロムヘキシン塩酸塩
A bromhexine product containing ブロムヘキシン塩酸塩, registered in Japan by Ｔ’ｓファーマ, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Bromhexine is registered in 15 of 19 countries.
Countries holding a registration under ATC R05CB02 (bromhexine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Bromhexine · ATC R05CB02
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ブロムヘキシン塩酸塩
- Manufacturer
- Ｔ’ｓファーマ
- Country
- Japan (JP)
- ATC code
- R05CB02
- ATC class
- Bromhexine
- Defined daily dose
- 24 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R05CB02
Bromhexine, as other registers publish it.
- NetherlandsAlbert Heijn Broomhexine HCl hoesttabletten 8 mg, tablettenSameko Farma B.V.
- NetherlandsAlbert Heijn Hoestdrank Broomhexine HCl 4 mg/5 ml, drankHealthypharm B.V.
- NetherlandsAlbert Heijn Hoestdrank Broomhexine HCl 8 mg/5 ml, drankHealthypharm B.V.
- FinlandBisolvonBoehringer Ingelheim International GmbH
- FinlandBisolvonOpella Healthcare France SAS
- FinlandBisolvonOrion Corporation Orion Pharma
- FinlandBisolvonOpella Healthcare France SAS
- NorwayBisolvonOpella Healthcare France SAS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc55ab95-6c02-488e-abcf-56354a20cb14 GET /v1/drugs/bc55ab95-6c02-488e-abcf-56354a20cb14?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．２％２ｍＬ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2234400A1054",
"category": "注射薬",
"price_yen": 63,
"generic_name": "ブロムヘキシン塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2234",
"transitional_expiry": null
}See everything about bromhexine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.